Fertility Preservation Network Welcomes Spokane, Washington Area Facility

Program greatly extends access to Fertility Preservation services.

St. Paul, MN, October 16, 2014 --(PR.com)-- ReproTech, Ltd., the leading cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), has reached an agreement with Seattle Reproductive Medicine’s Spokane, WA location.

Seattle Reproductive Medicine, with offices in Seattle, Bellevue, Tacoma, Kirkland, and Spokane, WA, joins the more than 100 facilities included in ReproTech’s Fertility Preservation Network. The growing network of fertility centers provides much needed Fertility Preservation services to cancer patients prior to the initiation of oncology treatments.

“This is a very valuable service for cancer patients,” says Brent Hazelrigg, President and CEO of ReproTech, Ltd. “With the growing success of cancer therapies and tremendous advancements in fertility treatment, cancer survivors today have an excellent chance of having families provided they are given the opportunity to cryopreserve reproductive tissue prior to their oncology treatment.”

Dr. Brenda Houmard, MD of Seattle Reproductive Medicine-Spokane says “SRM Spokane opened one year ago and is pleased to bring services, such as fertility preservation for oncology patients, to the Inland Northwest.”

Dr. Lynn Davis, MD of Seattle Reproductive Medicine adds, “SRM’s new Spokane location is pleased to be a part of ReproTech’s Fertility Preservation Network. We look forward to our practices enabling patients faced with oncology treatments to have options for fertility preservation, including freezing their specimens for future family building.”

According to the American Cancer Society, 140,000 men and women of childbearing age are newly diagnosed with cancer each year. There often is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. Both the American Society of Clinical Oncology (ASCO) and American Society for Reproductive Medicine (ASRM) recommend the education of oncology patients about the options available to preserve their fertility.

ReproTech, Ltd. has organized the Fertility Preservation Network to educate oncology professionals and caretakers, as well as provide much needed cryopreservation services. The Network now includes members in 36 states and the Caribbean. Additionally, the work of the Fertile Hope and the LIVESTRONG Fertility Program has advanced the awareness of the need for Fertility Preservation among the oncology community.

About ReproTech, Ltd.
ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates regional cryostorage centers in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at www.reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at www.fertilitypreservation.com.

About Seattle Reproductive Medicine
Opened in 2004, the SRM mission is to provide state of the art reproductive healthcare so that patients can lead happier, healthier lives. More information can be found at www.seattlefertility.com
ReproTech, Ltd.
Courtney Dennewitz